Logo

Icoria to ID Biomarkers for Isis Pharmaceuticals

Aug 24, 2005

NEW YORK, Aug. 24 (GenomeWeb News) - Icoria will identify biomarkers of toxicity in animal models for Isis Pharmaceuticals, the biotechnology company said yesterday.

Icoria will use its metabolomics platform to evaluate differences in treated and untreated animal subjects to identify biomarkers that Isis will use to suggest pathways for alteration by potential drug candidates, Icoria said.

Financial details were not disclosed.

Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.